| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000266912.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.036890186 |
Resistant |
| ENSG00000266912.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.042028248 |
Resistant |
| ENSG00000266912.1 |
Gefitinib |
Thyroid carcinoma |
0.026366797 |
Sensitive |
